Janux Therapeutics (JANX) Times Interest Earned (2020)

Janux Therapeutics (JANX) has reported Times Interest Earned for 7 consecutive years, with -$1.2 the latest figure, recorded in Q1 2026.

• In Q1 2026, Times Interest Earned fell 351.23% year-over-year to -$1.2; the TTM figure through Mar 2026 stood at -$5.51 (down 536.12% YoY), while the FY2025 annual figure was -$5.33, down 1848.8% from the prior year.
• Times Interest Earned slipped to -$1.2 in Q1 2026 per JANX's latest filing, from -$0.33 in the prior quarter.
• Across five years, Times Interest Earned topped out at -$0.05 in Q2 2024 and bottomed at -$53.1 in Q4 2022.
• Historically, Times Interest Earned has averaged -$4.22 across 5 years, with a median of -$0.46 in 2022.
• Annual changes were most pronounced in 2024 — Times Interest Earned soared 91.5% — and 2025, when it slumped 849.0%.
• Janux Therapeutics' Times Interest Earned stood at -$53.1 in 2022, then soared by 98.02% to -$1.05 in 2023, then soared by 89.1% to -$0.11 in 2024, then slumped by 188.57% to -$0.33 in 2025, then tumbled by 263.86% to -$1.2 in 2026.
• Business Quant data shows JANX's Times Interest Earned at -$1.2 in Q1 2026, -$0.33 in Q3 2025, and -$0.46 in Q2 2025.